Carcinoid syndrome risk factors: Difference between revisions
Jump to navigation
Jump to search
Line 9: | Line 9: | ||
*Age (50 years or older) | *Age (50 years or older) | ||
*Gender (female) | *Gender (female) | ||
*[[Multiple endocrine neoplasia type 1 | *[[Multiple endocrine neoplasia type 1|Multiple endocrine neoplasia type 1 (MEN1) syndrome]] | ||
*[[Neurofibromatosis type 1 | *[[Neurofibromatosis type 1|Neurofibromatosis type 1 (NF1) syndrome]] | ||
*[[Atrophic gastritis]] | *[[Atrophic gastritis]] | ||
*[[Pernicious anemia]] | *[[Pernicious anemia]] |
Revision as of 16:21, 29 September 2015
Carcinoid syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Carcinoid syndrome risk factors On the Web |
American Roentgen Ray Society Images of Carcinoid syndrome risk factors |
Risk calculators and risk factors for Carcinoid syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Overiew
Common risk factors in the development of carcinoid syndrome include age (50 years or older), gender (female), multiple endocrine neoplasia type 1 (MEN1) syndrome, neurofibromatosis type 1 (NF1) syndrome, atrophic gastritis, pernicious anemia, and Zollinger-Ellison syndrome.[1]
Risk Factors
Common risk factors in the development of carcinoid syndrome include:[1]
- Age (50 years or older)
- Gender (female)
- Multiple endocrine neoplasia type 1 (MEN1) syndrome
- Neurofibromatosis type 1 (NF1) syndrome
- Atrophic gastritis
- Pernicious anemia
- Zollinger-Ellison syndrome
References
- ↑ 1.0 1.1 Health history can affect the risk of gastrointestinal carcinoid tumors. National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/patient/gi-carcinoid-treatment-pdq